Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment

Geetha A. Subramaniam, Maxine L Stitzer, Philip Clemmey, Ken Kolodner, Marc J. Fishman

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. METHOD: In total, 153 adolescents (mean age 6.6 years, ± 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of ≥11 versus 2 years and having an opioid use disorder. CONCLUSIONS: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. Copyright 2007

Original languageEnglish (US)
Pages (from-to)1062-1069
Number of pages8
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume46
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Residential Treatment
Depression
Equipment and Supplies
Opioid Analgesics
Prospective Studies

Keywords

  • Adolescent substance use
  • Depressive symptoms
  • Treatment outcomes

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment. / Subramaniam, Geetha A.; Stitzer, Maxine L; Clemmey, Philip; Kolodner, Ken; Fishman, Marc J.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 46, No. 8, 08.2007, p. 1062-1069.

Research output: Contribution to journalArticle

@article{fa2888d8875848aaae2ece23455b1367,
title = "Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment",
abstract = "OBJECTIVE: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. METHOD: In total, 153 adolescents (mean age 6.6 years, ± 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of ≥11 versus 2 years and having an opioid use disorder. CONCLUSIONS: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. Copyright 2007",
keywords = "Adolescent substance use, Depressive symptoms, Treatment outcomes",
author = "Subramaniam, {Geetha A.} and Stitzer, {Maxine L} and Philip Clemmey and Ken Kolodner and Fishman, {Marc J.}",
year = "2007",
month = "8",
doi = "10.1097/chi.0b013e31806c7ad0",
language = "English (US)",
volume = "46",
pages = "1062--1069",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment

AU - Subramaniam, Geetha A.

AU - Stitzer, Maxine L

AU - Clemmey, Philip

AU - Kolodner, Ken

AU - Fishman, Marc J.

PY - 2007/8

Y1 - 2007/8

N2 - OBJECTIVE: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. METHOD: In total, 153 adolescents (mean age 6.6 years, ± 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of ≥11 versus 2 years and having an opioid use disorder. CONCLUSIONS: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. Copyright 2007

AB - OBJECTIVE: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. METHOD: In total, 153 adolescents (mean age 6.6 years, ± 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of ≥11 versus 2 years and having an opioid use disorder. CONCLUSIONS: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. Copyright 2007

KW - Adolescent substance use

KW - Depressive symptoms

KW - Treatment outcomes

UR - http://www.scopus.com/inward/record.url?scp=34547664915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547664915&partnerID=8YFLogxK

U2 - 10.1097/chi.0b013e31806c7ad0

DO - 10.1097/chi.0b013e31806c7ad0

M3 - Article

C2 - 17667484

AN - SCOPUS:34547664915

VL - 46

SP - 1062

EP - 1069

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 8

ER -